478 related articles for article (PubMed ID: 26044289)
1. Mortality Risk After AIDS-Defining Opportunistic Illness Among HIV-Infected Persons--San Francisco, 1981-2012.
Djawe K; Buchacz K; Hsu L; Chen MJ; Selik RM; Rose C; Williams T; Brooks JT; Schwarcz S
J Infect Dis; 2015 Nov; 212(9):1366-75. PubMed ID: 26044289
[TBL] [Abstract][Full Text] [Related]
2. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
[TBL] [Abstract][Full Text] [Related]
3. [AIDS and injecting drug use: survival determinants in the highly active antiretroviral therapy era].
Zucchetto A; Bruzzone S; De Paoli A; Regine V; Pappagallo M; Dal Maso L; Serraino D; Rezza G; Suligoi B
Epidemiol Prev; 2009; 33(4-5):184-9. PubMed ID: 20124634
[TBL] [Abstract][Full Text] [Related]
4. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
5. The association between cigarette smoking and selected HIV-related medical conditions.
Conley LJ; Bush TJ; Buchbinder SP; Penley KA; Judson FN; Holmberg SD
AIDS; 1996 Sep; 10(10):1121-6. PubMed ID: 8874629
[TBL] [Abstract][Full Text] [Related]
6. Survival trends for patients with AIDS.
Lemp GF; Payne SF; Neal D; Temelso T; Rutherford GW
JAMA; 1990 Jan; 263(3):402-6. PubMed ID: 2294307
[TBL] [Abstract][Full Text] [Related]
7. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991.
Jacobson LP; Kirby AJ; Polk S; Phair JP; Besley DR; Saah AJ; Kingsley LA; Schrager LK
Am J Epidemiol; 1993 Dec; 138(11):952-64. PubMed ID: 7903022
[TBL] [Abstract][Full Text] [Related]
8. Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance.
Schwarcz L; Chen MJ; Vittinghoff E; Hsu L; Schwarcz S
AIDS; 2013 Feb; 27(4):597-605. PubMed ID: 23079812
[TBL] [Abstract][Full Text] [Related]
9. Cryptosporidiosis among patients infected with human immunodeficiency virus. Factors related to symptomatic infection and survival.
Colford JM; Tager IB; Hirozawa AM; Lemp GF; Aragon T; Petersen C
Am J Epidemiol; 1996 Nov; 144(9):807-16. PubMed ID: 8890659
[TBL] [Abstract][Full Text] [Related]
10. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
[TBL] [Abstract][Full Text] [Related]
11. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.
; Mocroft A; Sterne JA; Egger M; May M; Grabar S; Furrer H; Sabin C; Fatkenheuer G; Justice A; Reiss P; d'Arminio Monforte A; Gill J; Hogg R; Bonnet F; Kitahata M; Staszewski S; Casabona J; Harris R; Saag M
Clin Infect Dis; 2009 Apr; 48(8):1138-51. PubMed ID: 19275498
[TBL] [Abstract][Full Text] [Related]
12. AIDS-defining opportunistic illnesses in the HAART era in New York City.
Hanna DB; Gupta LS; Jones LE; Thompson DM; Kellerman SE; Sackoff JE
AIDS Care; 2007 Feb; 19(2):264-72. PubMed ID: 17364409
[TBL] [Abstract][Full Text] [Related]
13. A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy.
Stebbing J; Sanitt A; Nelson M; Powles T; Gazzard B; Bower M
Lancet; 2006 May; 367(9521):1495-502. PubMed ID: 16679162
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.
Ylitalo N; Brogly S; Hughes MD; Nachman S; Dankner W; Van Dyke R; Seage GR;
Arch Pediatr Adolesc Med; 2006 Aug; 160(8):778-87. PubMed ID: 16894075
[TBL] [Abstract][Full Text] [Related]
15. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993.
Osmond D; Charlebois E; Lang W; Shiboski S; Moss A
JAMA; 1994 Apr; 271(14):1083-7. PubMed ID: 7908703
[TBL] [Abstract][Full Text] [Related]
16. [Survival of patients following the diagnosis of AIDS in the Amsterdam region, 1982-1991].
Bindels PJ; Krol A; Mulder-Folkerts DK; van den Hoek JA; Coutinho RA
Ned Tijdschr Geneeskd; 1994 Mar; 138(10):513-8. PubMed ID: 8139710
[TBL] [Abstract][Full Text] [Related]
17. Survival rate of AIDS disease and mortality in HIV-infected patients in Hamadan, Iran: a registry-based retrospective cohort study (1997-2011).
Mirzaei M; Poorolajal J; Khazaei S; Saatchi M
Int J STD AIDS; 2013 Nov; 24(11):859-66. PubMed ID: 23970604
[TBL] [Abstract][Full Text] [Related]
18. Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group.
Mocroft AJ; Lundgren JD; d'Armino Monforte A; Ledergerber B; Barton SE; Vella S; Katlama C; Gerstoft J; Pedersen C; Phillips AN
Int J Epidemiol; 1997 Apr; 26(2):400-7. PubMed ID: 9169177
[TBL] [Abstract][Full Text] [Related]
19. Mortality associated with mode of presentation in the acquired immune deficiency syndrome.
Moss AR; McCallum G; Volberding PA; Bacchetti P; Dritz S
J Natl Cancer Inst; 1984 Dec; 73(6):1281-4. PubMed ID: 6334770
[TBL] [Abstract][Full Text] [Related]
20. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.
Dankner WM; Lindsey JC; Levin MJ;
Pediatr Infect Dis J; 2001 Jan; 20(1):40-8. PubMed ID: 11176565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
